| | | | | | | | | | |
|
|
| Dockets Entered
On April 19, 2006
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1977P-0403
|
| Model 2001 light show laser projector
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
| 2000N-1396
|
| Bioengineered Foods Consumed By Humans or Animals
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| 2002P-0211
|
| Amend 21CFR163,"Cacao Products: Stds of Identity"
|
|
|
| 2002V-0453
|
| Laser Light Show
|
|
|
| 2004N-0408
|
| Regulatory Site Visit Training Program
|
|
|
| 2005D-0195
|
| Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
|
|
|
| 2005P-0213
|
| To change the classification of EEG electrodes currently classified as class II and requiring 510K approvals\
|
|
|
| 2005P-0377
|
| Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2005P-0420
|
| Establish therapeutic equivalence requirements for any generic or following-on drug product referencing Adderall XR MASP
|
|
|
| 2005P-0423
|
| Immediately add a black box warning regarding the risks of drug-induced blindness for the three phosphodiesterase 5 inhibitors that are prescribed for the treatment of erectile dysfuntion
|
|
|
| 2005V-0188
|
| Laser Light Show
|
|
|
| 2005V-0499
|
| Laser Pointer/Illuminator products GCP-1A. GCP-2
|
|
|
| 2006D-0066
|
| Guidance for Industry and FDA Staff: Whole Grains Label Statements
|
|
|
| 2006N-0036
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosur
|
|
|
|
| 2006N-0037
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Trans Fat Claims on Foods
|
|
|
| 1977P-0403
|
| Model 2001 light show laser projector
|
|
|
| VRA 14
|
| HFZ-200 to Laser Production Network
|
| Vol #:
|
| 1
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
| C 10014
|
| R. Maccarsey
|
| Vol #:
|
| 580
|
|
|
| 2000N-1396
|
| Bioengineered Foods Consumed By Humans or Animals
|
|
| C 9618
|
| R. Maccarsey
|
| Vol #:
|
| 415
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| C 1379
|
| P. Kremer
|
| Vol #:
|
| 259
|
|
|
| 2002P-0211
|
| Amend 21CFR163,"Cacao Products: Stds of Identity"
|
|
|
| PDN 1
|
| HFC-1 to American Environmental Safety Institute
|
| Vol #:
|
| 1
|
|
|
| 2002V-0453
|
| Laser Light Show
|
|
|
| VRA 3
|
| HFZ-200 to Optical Magic
|
| Vol #:
|
| 1
|
|
|
| 2004N-0408
|
| Regulatory Site Visit Training Program
|
|
| | | | | | | | |
|
|
| EC 31570
|
| Mrs. Mary Gessner
|
| Vol #:
|
| 111
|
|
|
| 2005P-0420
|
| Establish therapeutic equivalence requirements for any generic or following-on drug product referencing Adderall XR MASP
|
|
|
| LET 2
|
| HFD-005 to Shire Pharmaceuticals Group
|
| Vol #:
|
| 2
|
|
|
| 2005P-0423
|
| Immediately add a black box warning regarding the risks of drug-induced blindness for the three phosphodiesterase 5 inhibitors that are prescribed for the treatment of erectile dysfuntion
|
|
|
|
|
|
|
| LET 1
|
| HFD-005 to Public Citzen's Health Research Group
|
| Vol #:
|
| 1
|
|
|
| 2005V-0188
|
| Laser Light Show
|
|
|
| VRA 1
|
| HFZ-200 to Best Entertainment
|
| Vol #:
|
| 1
|
|
|
| 2005V-0499
|
| Laser Pointer/Illuminator products GCP-1A. GCP-2
|
|
| VRA 2
|
| HFZ-200 to NVEC (Night Vision Equipment Company)
|
| Vol #:
|
| 1
|
|
|
| 2006D-0066
|
| Guidance for Industry and FDA Staff: Whole Grains Label Statements
|
|
|
| C 16
|
| Independent Bakers Association (IBA)
|
| Vol #:
|
| 1
|
|
|
| C 17
|
| Pizzey Milling (Pizzey)
|
| Vol #:
|
| 3
|
|
|
| 2006N-0036
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosur
|
|
|
|
|
|
| C 2
|
| Food Products Association (FPA)
|
| Vol #:
|
| 1
|
|
|
| 2006N-0037
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Trans Fat Claims on Foods
|
|
|
| C 1
|
| Food Products Association (FPA)
|
| Vol #:
|
| 1
|
|